Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future

Wenxi Fang1,2, Saiyang Xie1,2, Wei Deng3,4

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan, 430060, People's Republic of China.

PubMed

Insights

Ferroptosis, a cell death pathway, is increasingly recognized as a key factor in cardiovascular diseases (CVDs). Understanding ferroptosis mechanisms offers new therapeutic targets for treating heart conditions.

Area of Science:

  • Biomedical Science
  • Cardiology
  • Cell Biology

Background:

  • Cardiovascular diseases (CVDs) pose a significant global health burden, characterized by high morbidity and hospitalization rates.
  • Cell death, particularly ferroptosis, is a critical pathophysiological process underlying various CVDs.

Purpose of the Study:

  • To review the latest research on ferroptosis mechanisms in cardiovascular diseases.
  • To explore ferroptosis's role in the development and treatment of CVDs.
  • To identify novel therapeutic targets for CVDs based on ferroptosis pathways.

Main Methods:

  • Literature review of recent scientific research on ferroptosis and CVDs.
  • Analysis of ferroptosis's involvement in iron regulation, metabolism, and lipid peroxidation.
  • Synthesis of findings related to ferroptosis in specific cardiovascular conditions.

Main Results:

  • Ferroptosis is implicated in a wide range of CVDs, including myocardial infarction, heart failure, and various cardiomyopathies.
  • The process involves critical pathways such as iron regulation, metabolic reprogramming, and lipid peroxidation.
  • Ferroptosis plays a significant role in the pathophysiology of cardiovascular conditions.

Conclusions:

  • Ferroptosis is a crucial mechanism in the development of cardiovascular diseases.
  • Targeting ferroptosis pathways presents promising avenues for novel CVD treatments.
  • Further research into ferroptosis can lead to improved clinical diagnosis and therapeutic strategies for CVDs.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K